Loading...
Predicting the future of anti-tumor necrosis factor therapy
Tumor necrosis factor (TNF) antagonists are approved worldwide for the treatment of rheumatoid arthritis (RA). Clinical experience revealed that TNF-blocking therapy is effective for only approximately two thirds of patients, reflecting that there are 'responders' as well as 'nonrespo...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2714140/ https://ncbi.nlm.nih.gov/pubmed/19591638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar2724 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|